Reliv reported net sales of $10.0 million for the second quarter of 2017 compared with net sales of $11.1 million in the second quarter of 2016.
Net sales in the United States decreased to $7.5 million in the second quarter of 2017 compared to $8.4 million in the prior-year quarter. Net sales in Reliv’s foreign markets decreased 5.2 percent in the second quarter of 2017 compared with the prior-year second quarter.
Foreign sales increased by 2.8 percent when the impact of foreign currency fluctuation is removed as the result of a stronger U.S. dollar. An increase of 74.2 percent in net sales in Asia in the second quarter of 2017 was offset by a decline of 19.3 percent in net sales in Europe, along with decreases in other regions. Net sales in Europe declined by 9.5 percent when the impact of foreign currency fluctuation is removed.
Reliv reported a net loss for the second quarter of 2017 of $520,000 (loss per diluted share of $0.28) compared to a net loss of $988,000 (loss per diluted share of $0.54) in the second quarter of 2016. The loss per diluted share for the second quarter of 2016 has been adjusted for the one-for-seven reverse stock
Tag Archive for Reliv
Hot Business News Today
Reliv 2016 Q4 Sales Down 12% To $10.6 Million
by Nicole Dunkley • • 0 Comments
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2016.
Fourth-Quarter Results
Reliv reported net sales of $10.6 million for the fourth quarter of 2016, compared with net sales of $12.3 million for the fourth quarter of 2015. U.S. net sales decreased by 12.1 percent for the quarter compared with the same quarter in 2015.
Net sales outside of the United States declined 18.4 percent in the fourth quarter of 2016 compared to the prior-year quarter, with 10.7 percent of that decline due to the impact of foreign currency fluctuation as the result of a stronger U.S. dollar.
Reliv reported net income of $272,000, or earnings of $0.15 per diluted share, for the fourth quarter of
Hot Business News Today
Reliv Reports Q2 Sales Down 12.9% To $11.1 Million
by Nicole Dunkley • • 0 Comments
Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today reported its financial results for the second quarter of 2016.
Reliv reported net sales of $11.1 million for the second quarter of 2016 compared with net sales of $12.4 million in the second quarter of 2015. U.S. net sales decreased to $8.4 million from $9.6 million, a decline of 12.9 percent.
Net sales in Reliv’s foreign markets for the second quarter of 2016 decreased 5.5 percent compared with net sales in the prior-year second quarter. Excluding the impact of foreign currency fluctuation as the result of a stronger U.S. dollar, foreign sales increased by 0.7 percent in the second quarter of 2016 compared to the prior-year quarter.
Reliv reported a net loss for the second quarter of 2016 of $988,000 (loss
Hot Business News Today
Reliv Reports 2016 Q1 Results – Net Sales Down 10.7% To $13 Million
by Nicole Dunkley • • 0 Comments
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, recently reported its financial results for the first quarter of 2016.
Reliv reported net sales of $13.0 million for the first quarter of 2016 compared with net sales of $14.8 million in the first quarter of 2015. U.S. net sales decreased to $10.3 million from $11.5 million, a decline of 10.7 percent.
Net sales in Reliv’s foreign markets for the first quarter of 2015 decreased 17.1 percent compared with net sales in the prior-year first quarter with 6.5 percent of the decline due to the impact of foreign currency fluctuation as the result of a stronger U.S. dollar.
Reliv reported a net loss for the first quarter of 2016 of $44,000 (loss per diluted share of $0.00) compared to net
Hot Business News Today
Reliv Reports Q4 And Full Year 2015 Financial Results
by Nicole Dunkley • • 0 Comments
Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2015.
Reliv reported net sales of $12.3 million for the fourth quarter of 2015, compared with net sales of $14.1 million for the fourth quarter of 2014. U.S. net sales decreased by 12.1 percent for the quarter compared with the same quarter in 2014.
Net sales outside of the United States declined 14.9 percent in the fourth quarter of 2015 compared to the prior-year quarter, with 7.3 percent of that decline due to the impact of foreign currency fluctuation as the result of a stronger U.S. dollar.
Reliv reported net sales of $51.8 million for 2015 compared with net sales of $57.3 million in 2014. U.S. net sales decreased
Hot Business News Today
Reliv Receives Expanded Patent For LunaRich
by Nicole Dunkley • • 0 Comments
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that the U.S. Patent and Trademark Office has issued an expanded patent for LunaRich, Reliv’s exclusive nutritional ingredient. The updated patent further protects LunaRich technology as it relates to the soy peptide lunasin’s mechanism of action for lowering LDL cholesterol levels.
Lunasin is a naturally occurring peptide scientists have identified as the key to many of soy’s documented health benefits. LunaRich optimizes bioactive lunasin more than any other source available today.
“Novel ingredients like LunaRich that boast a spectrum of nutritional technologies often require continual patent updates,” said Dr. Carl W. Hastings, Reliv vice chairman and chief scientific officer. “Reliv is committed to securing the strongest patent portfolio possible for this remarkable nutritional ingredient.”
Reliv also holds a composition
Hot Business News Today
Reliv 2015 Q2 – Net Sales Down 14% To $12.4 Million
by Nicole Dunkley • • 0 Comments
Reliv International, Inc., a maker of nutritional supplements that promote optimal health reported its financial results for the second quarter of 2015.
Net sales for the quarter were $12.4 million, a 14.0 percent decrease from the second quarter last year. Net U.S. sales totaled $9.6 million, down from $10.8 million in the second quarter of 2014. Net sales outside of the United States decreased 22.1 percent in the second quarter of 2015 compared to the prior-year quarter. Foreign currency fluctuation accounted for 8.7 percent of the net sales decline outside of the United States. Net sales in Europe declined 30.7 percent in the second quarter of 2015 compared to the prior-year quarter, with foreign currency fluctuation accounting for 6.8 percent of the decline.
The net loss for the second quarter of 2015 was $846,000
Hot Business News Today
Reliv 2015 Q1 Net Sales Up 7.4% To $14.8 Million
by Nicole Dunkley • • 0 Comments
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, reported its financial results for the first quarter of 2015.
Reliv reported net sales of $14.8 million for the first quarter of 2015, compared to net sales of $14.5 million for the first quarter of 2014. U.S. net sales increased 7.4 percent for the quarter compared to the same quarter in 2014. International net sales for the quarter decreased 11.1 percent, with a stronger U.S. dollar accounting for 8.0 percent of the decline.
The Company reported net income of $116,000, or $0.01 per diluted share, for the first quarter of 2015 compared to a net loss of $151,000, or ($0.01) per diluted share, for the first quarter of 2014. Income from operations for the first quarter of 2015 was $429,000 compared
Hot Business News Today
Reliv Down 19.8% In Q4 – 2014 To $14.1Million
by Nicole Dunkley • • 0 Comments
Reliv International, Inc, a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2014.
Reliv reported net sales of $14.1 million for the fourth quarter of 2014, compared with sales of $17.4 million for the fourth quarter of 2013. U.S. sales decreased by 19.8 percent for the quarter compared with the same quarter in 2013.
A significant portion of the decline in U.S. net sales was due to a promotion launched in fall 2013 that lowered the sales volume level needed to qualify as a Master Affiliate in the United States.
This resulted in a shifting of and reduction in requalification orders that would normally be received in January 2014 to the fourth quarter of 2013. International sales for the quarter decreased 16.0
Hot Business News Today
Reliv International Q3 Results – Down 13.5% To $10.9 Million
by Nicole Dunkley • • 0 Comments
Reliv International, Inc., a maker of nutritional supplements that promote optimal health, reported its financial results for the third quarter of 2014.
Net sales for the quarter were $14.3 million, a 13.5 percent decrease from the third quarter last year. U.S. net sales totaled $10.9 million, a decrease of $2.2 million, or 16.8 percent, compared to third-quarter 2013 net sales.
Net sales outside of the United States declined slightly at 0.2 percent in the third quarter of 2014 compared to the prior-year quarter, offset by the European market where net sales increased by 16.1 percent.
Net income for the third quarter of 2014 was $166,000 or $0.01 per diluted share, compared to $293,000 or $0.02 per diluted share in the 2013 third quarter. In the second quarter of 2014, Reliv reported a net loss of $289,000 or $0.02 per diluted share.
Reliv’s sequential profitability improvement is attributable to effective cost reduction measures enacted in the third quarter and the tax benefit related to the liquidation of Reliv’s former entity in Germany. Income from operations for the third quarter of 2014 was $228,000 compared to $402,000 in the same quarter of 2013.
“Reliv has recently completed a series of critical transitions — in our distributor field,